Cc1ccn2c(NC3CCCCC3)c(-c3cccc(-c4cccc(Cl)c4)c3)nc2c1.O=C(O)C(F)(F)F
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?